These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11035256)

  • 1. Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2).
    Chen S; Wu K; Knox R
    Free Radic Biol Med; 2000 Aug; 29(3-4):276-84. PubMed ID: 11035256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling.
    Chen S; Wu K; Zhang D; Sherman M; Knox R; Yang CS
    Mol Pharmacol; 1999 Aug; 56(2):272-8. PubMed ID: 10419545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A site-directed mutagenesis study at Lys-113 of NAD(P)H:quinone-acceptor oxidoreductase: an involvement of Lys-113 in the binding of the flavin adenine dinucleotide prosthetic group.
    Tedeschi G; Deng PS; Chen HH; Forrest GL; Massey V; Chen S
    Arch Biochem Biophys; 1995 Aug; 321(1):76-82. PubMed ID: 7639539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DT-diaphorase. Redox potential, steady-state, and rapid reaction studies.
    Tedeschi G; Chen S; Massey V
    J Biol Chem; 1995 Jan; 270(3):1198-204. PubMed ID: 7836380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants.
    Rashid MH; Babu D; Siraki AG
    Chem Biol Interact; 2021 Aug; 345():109574. PubMed ID: 34228969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.
    Gaikwad NW; Yang L; Rogan EG; Cavalieri EL
    Free Radic Biol Med; 2009 Jan; 46(2):253-62. PubMed ID: 18996184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.
    Ordoñez ID; Cadenas E
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):481-90. PubMed ID: 1530580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
    Knox RJ; Jenkins TC; Hobbs SM; Chen S; Melton RG; Burke PJ
    Cancer Res; 2000 Aug; 60(15):4179-86. PubMed ID: 10945627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity.
    Megarity CF; Timson DJ
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
    Friedlos F; Jarman M; Davies LC; Boland MP; Knox RJ
    Biochem Pharmacol; 1992 Jul; 44(1):25-31. PubMed ID: 1385952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and partial purification of microsomal NAD(P)H:quinone oxidoreductases.
    Jaiswal AK
    Arch Biochem Biophys; 2000 Mar; 375(1):62-8. PubMed ID: 10683249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.
    Kucera HR; Livingstone M; Moscoso CG; Gaikwad NW
    Free Radic Res; 2013 Dec; 47(12):1016-26. PubMed ID: 24074361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse NRH:quinone oxidoreductase (NQO2): cloning of cDNA and gene- and tissue-specific expression.
    Long DJ; Jaiswal AK
    Gene; 2000 Jul; 252(1-2):107-17. PubMed ID: 10903442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of histidine-194, aspartate-163, and a glycine-rich sequence of NAD(P)H:quinone oxidoreductase in the interaction with nicotinamide coenzymes.
    Cui K; Ma Q; Lu AY; Yang CS
    Arch Biochem Biophys; 1995 Nov; 323(2):265-73. PubMed ID: 7487087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
    Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
    Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places.
    Pey AL; Megarity CF; Timson DJ
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
    Joseph P; Jaiswal AK
    Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.